Fig. 2From: Can incorporating genotyping data into efficacy estimators improve efficiency of early phase malaria vaccine trials?Infection durations for 8 hypothetical trial participants (Panel A), observed genotyping data and information contributing to VEmolFOI (Panel B), and information incorporated into VEC (Panel C)Back to article page